logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On January 9th, HSBC Holdings (00005) spent approximately HK$35.61 million to repurchase 468,800 shares in Hong Kong.

date
17:26 10/01/2025
avatar
GMT Eight
HSBC Holdings (00005) announced that it will repurchase approximately 10,780,500 in the UK on January 9, 2025.
HSBC Holdings (00005) announced that on January 9, 2025, it will spend approximately 10.78 million to repurchase around 135.25 million shares in the UK, and approximately HK$35.6123 million to repurchase about 46.88 million shares in Hong Kong.
Related Articles
HK Stock
LAJIN ENT(08172): The listing committee has decided to maintain the temporary suspension of the company's trading of shares.
HK Stock
LEADS BIOLABS-B(09887): One LBL-034 clinical study has been selected to be the first oral presentation on the first day of the 67th ASH Annual Meeting.
China Stock
Sinolink: Northbound capital flows back, margin trading activity reaches nearly three-week high
LAJIN ENT(08172): The listing committee has decided to maintain the temporary suspension of the company's trading of shares.
HK Stock
LEADS BIOLABS-B(09887): One LBL-034 clinical study has been selected to be the first oral presentation on the first day of the 67th ASH Annual Meeting.
HK Stock
Sinolink: Northbound capital flows back, margin trading activity reaches nearly three-week high
China Stock
RECOMMEND
Where the blockbuster weight-loss drug market stands today — and what’s coming next
Where the blockbuster weight-loss drug market stands today — and what’s coming next
icon
03/11/2025
Where the Nexperia auto-chip dispute stands as the U.S., China and EU move to contain the fallout
Where the Nexperia auto-chip dispute stands as the U.S., China and EU move to contain the fallout
icon
03/11/2025
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
icon
30/10/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.